Onder, F. O. Et Al. 2012. Can response to pegylated interferon treatment in chronic delta hepatitis be predicted with on-treatment parameters?. 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , (Massachusetts, United States Of America).

Onder, F. O., Erhardt, A., Idilman, R., Keskin, O., Dalekos, G. N., Yalcin, K., ... Manns, M. P.(2012). Can response to pegylated interferon treatment in chronic delta hepatitis be predicted with on-treatment parameters? . 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America

Onder, Fatih Et Al. "Can response to pegylated interferon treatment in chronic delta hepatitis be predicted with on-treatment parameters?," 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 2012

Onder, Fatih O. Et Al. "Can response to pegylated interferon treatment in chronic delta hepatitis be predicted with on-treatment parameters?." 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , Massachusetts, United States Of America, 2012

Onder, F. O. Et Al. (2012) . "Can response to pegylated interferon treatment in chronic delta hepatitis be predicted with on-treatment parameters?." 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , Massachusetts, United States Of America.

@conferencepaper{conferencepaper, author={Fatih Oğuz ÖNDER Et Al. }, title={Can response to pegylated interferon treatment in chronic delta hepatitis be predicted with on-treatment parameters?}, congress name={63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)}, city={Massachusetts}, country={United States Of America}, year={2012}}